VOYA Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.31M | Sell |
|
|||||
|
2025
Q1 | $3.73M | Sell |
|
|||||
|
2024
Q4 | $4.71M | Sell |
|
|||||
|
2024
Q3 | $6.72M | Buy |
|
|||||
|
2024
Q2 | $5.23M | Sell |
|
|||||
|
2024
Q1 | $5.08M | Buy |
|
|||||
|
2023
Q4 | $4.95M | Sell |
|
|||||
|
2023
Q3 | $6.57M | Buy |
|
|||||
|
2023
Q2 | $5.53M | Buy |
|
|||||
|
2023
Q1 | $5.04M | Sell |
|
|||||
|
2022
Q4 | $8.81M | Buy |
|
|||||
|
2022
Q3 | $7.91M | Buy |
|
|||||
|
2022
Q2 | $6.02M | Buy |
|
|||||
|
2022
Q1 | $1.2M | Buy |
|
|||||
|
2021
Q4 | $987K | Buy |
|
|||||
|
2021
Q3 | $995K | Sell |
|
|||||
|
2021
Q2 | $1.12M | Sell |
|
|||||
|
2021
Q1 | $789K | Buy |
|
|||||
|
2020
Q4 | $571K | Buy |
|
|||||
|
2020
Q3 | $202K | Buy |
|
|||||
|
2020
Q2 | $252K | Sell |
|
|||||
|
2020
Q1 | $156K | Buy |
|
|||||
|
2019
Q4 | $249K | Buy |
|
|||||
|
2019
Q3 | $131K | Hold |
|
|||||
|
2019
Q2 | $173K | Hold |
|
|||||
|
2019
Q1 | $371K | Hold |
|
|||||
|
2018
Q4 | $368K | Buy |
|
|||||
|
2018
Q3 | $322K | Hold |
|
|||||
|
2018
Q2 | $242K | Hold |
|
|||||
|
2018
Q1 | $201K | Hold |
|
|||||
|
2017
Q4 | $207K | Buy |
|
|||||
|
2017
Q3 | $201K | Hold |
|
|||||
|
2017
Q2 | $213K | Buy |
|
|||||
|
2017
Q1 | $287K | Hold |
|
|||||
|
2016
Q4 | $216K | Hold |
|
|||||
|
2016
Q3 | $151 | Hold |
|
|||||
|
2016
Q2 | $97K | Hold |
|
|||||
|
2016
Q1 | $97K | Hold |
|
|||||
|
2015
Q4 | $352K | Hold |
|
|||||
|
2015
Q3 | $389K | Sell |
|
|||||
|
2015
Q2 | $600K | Hold |
|
|||||
|
2015
Q1 | $363K | Hold |
|
|||||
|
2014
Q4 | $489K | Hold |
|
|||||
|
2014
Q3 | $393K | Hold |
|
|||||
|
2014
Q2 | $513K | Buy |
|